Foresight Group (Foresight), a listed private equity and infrastructure investment manager, has led a £1.7 million funding round into Nebu~Flow, an innovative medical device company developing surface acoustic wave (SAW) nebulisers, enabling the delivery of next-generation respiratory pharmaceuticals.
The investment round was led by Foresight Williams Technology (FWT), a joint venture between Foresight and Williams Advanced Engineering (WAE).
